Trial Profile

Improving equitable access and adherence to secondary Prevention therapy with a Fixed-Dose Combination Drug

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 05 Jun 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aspirin/ramipril/simvastatin (Primary) ; Aspirin; Ramipril; Simvastatin
Indications Embolism and thrombosis; Myocardial infarction; Myocardial ischaemia
Focus Therapeutic Use
Acronyms FOCUS

Most Recent Events

14 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
23 Jul 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
02 Jun 2012 Additional lead trial centre identified as reported by European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com